These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4423766)

  • 1. Interference of triameterene with cortisol determination in urine.
    Radó JP; Végh L; Sawinsky I
    Horm Metab Res; 1974 Sep; 6(5):429-30. PubMed ID: 4423766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Elimination of triamterene, an antikaliuretic, and its phenolic metabolite, 2,4,7-triamino-6-p-hydroxyphenylpteridine, in the urine of subjects with normal liver function and in subjects suffering from liver cirrhosis].
    Andrasch H; Fink T; Schmid E
    Z Gastroenterol; 1971; 9(4):240-5. PubMed ID: 5164739
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P
    Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chromatographic study of urinary 17-ketosteroids in liver cirrhosis. Degradation of cortisol].
    LOTTI G; LAMEDICA G; MARCENARO G
    Arch Maragliano Patol Clin; 1959 Oct; 15():1577-88. PubMed ID: 14418407
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered hydroxylation rate of triamterene in patients with liver cirrhosis.
    Gundert-Remy U; Müller-Herrmann R; Mutschler E; Schäfer M; Weber E
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):353-7. PubMed ID: 7118322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of triamterene and its main metabolite hydroxytriamterene sulfate in human urine by capillary electrophoresis using ultraviolet absorbance and laser-induced fluorescence detection.
    Horstkötter C; Kober S; Spahn-Langguth H; Mutschler E; Blaschke G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Mar; 769(1):107-17. PubMed ID: 11936683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Triamterene in the treatment of liver cirrhosis with ascites].
    Rodes J; Bosch J; Arroyo V; Nicolau I; Teres J; Bruguera M
    Rev Clin Esp; 1972 Dec; 127(6):1101-8. PubMed ID: 4663288
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-statistical observations on the use of triamterene in hepatic cirrhosis in the ascitic phase].
    Cairella M; De Martiis M; Nasta G
    Clin Ter; 1968 Aug; 46(3):198-202. PubMed ID: 5757655
    [No Abstract]   [Full Text] [Related]  

  • 9. [Triamterene in the depletive treatment of cirrhosis].
    Ravenni G; Rubegni M; Forconi S
    Boll Soc Ital Biol Sper; 1964 Apr; 40(7):290-3. PubMed ID: 5875781
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thin layer chromatographic determination of talinolol, propranolol and triamterene in urine: compliance evaluation of hypertensive patients].
    Molling J; Leuschner U; Meyer FP; Walther H
    Pharmazie; 1986 Apr; 41(4):301-2. PubMed ID: 2873599
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diuretic effect of triamterene in 20 patients with hepatic cirrhosis with ascites].
    Plaza de los Reyes M; Bardi A; Merino I; Domínguez JP; Poblete E; Penna M; Doerr E; Generini G
    Rev Med Chil; 1965 Sep; 93(9):544-8. PubMed ID: 5888084
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of triamterene on potassium excretion in cirrhotic patients receiving furosemide.
    Thompson EJ; Torres E; Grosberg SJ; Martinez-Maldonado M
    Clin Pharmacol Ther; 1977 Apr; 21(4):392-4. PubMed ID: 321176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicommuted flow-through fluorescence optosensor for determination of furosemide and triamterene.
    Llorent-Martínez EJ; Ortega-Barrales P; Molina-Díaz A
    Anal Bioanal Chem; 2005 Nov; 383(5):797-803. PubMed ID: 16211379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controlled clinical trial of the association of furosemide and triamterene].
    Azzi E; Perraro F
    Clin Ter; 1971 Mar; 56(6):501-22. PubMed ID: 5131091
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical and biochemical study of the therapeutic effect of the diuretic triamterene in ascitogenic cirrhosis].
    Păunescu-Podanu A; Demirian H; Ionitã C; Georgescu D; Tarachiu A; Anghel R; Rubingher L
    Med Interna (Bucur); 1968 May; 20(5):523-30. PubMed ID: 5735425
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of the suppressed potassium excretion during treatment with combinations of antikaliuretic drugs (spironolactone, canrenone, triamterene, amiloride) in patients with liver cirrhosis.
    Radó JP; Sawinsky I; Juhos E
    Int J Clin Pharmacol Biopharm; 1976 Oct; 14(3):163-7. PubMed ID: 1002353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute pancytopenia in a cirrhotic patient treated by triamterene. A new case].
    Pillegand B; Tournier C; Rumeau JM; Claude R
    Nouv Presse Med; 1977 Oct; 6(33):3004-5. PubMed ID: 304211
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantification of cortisol inactivation in cirrhosis of the liver.
    Vogeser M; Fischer G; Jacob K
    Exp Clin Endocrinol Diabetes; 1998; 106(5):410-4. PubMed ID: 9831307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of plasma and urinary cortisol by high-performance liquid chromatography using fluorescence derivatization with dansyl hydrazine.
    Kawasaki T; Maeda M; Tsuji A
    J Chromatogr; 1979 Jun; 163(2):143-50. PubMed ID: 541365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute pancytopenia and medullary megaloblastosis in a cirrhotic patient treated with triamterene].
    Renoux M; Bernard JF; Amar M; Boivin P
    Nouv Presse Med; 1976 Mar; 5(10):641-2. PubMed ID: 1264591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.